Skip to main content
Top
Published in: Pathology & Oncology Research 3/2018

01-07-2018 | Original Article

Distribution of Vascular Patterns in Different Subtypes of Renal Cell Carcinoma. A Morphometric Study in Two Distinct Types of Blood Vessels

Authors: Amparo Ruiz-Saurí, V. García-Bustos, E. Granero, S. Cuesta, M. A. Sales, V. Marcos, A. Llombart-Bosch

Published in: Pathology & Oncology Research | Issue 3/2018

Login to get access

Abstract

To analyze the presence of mature and immature vessels as a prognostic factor in patients with renal cell carcinoma and propose a classification of renal cancer tumor blood vessels according to morphometric parameters. Tissue samples were obtained from 121 renal cell carcinoma patients who underwent radical nephrectomy. Staining with CD31 and CD34 was used to differentiate between immature (CD31+) and mature (CD34+) blood vessels. We quantified the microvascular density, microvascular area and different morphometric parameters: maximum diameter, minimum diameter, major axis, minor axis, perimeter, radius ratio and roundness. We found that the microvascular density was higher in CD31+ than CD34+ vessels, but CD34+ vessels were larger than CD31+ vessels, as well as being strongly correlated with the ISUP tumor grade. We also identified four vascular patterns: pseudoacinar, fascicular, reticular and diffuse. Pseudoacinar and fascicular patterns were more frequent in clear cell renal cell carcinoma (37.62 and 35.64% respectively), followed by reticular pattern (21.78%), while in chromophobe tumors the reticular pattern predominated (90%). The isolated pattern was present in all papillary tumors (100%). In healthy renal tissue, the pseudoacinar and isolated patterns were differentially found in the renal cortex and medulla respectively. We defined four distinct vascular patterns significantly related with the ISUP tumor grade in renal cell carcinomas. Further studies in larger series are needed in order to validate these results. Analysis of both mature and immature vessels (CD34+ and CD31+) provides additional information when evaluating microvascular density.
Literature
1.
go back to reference Zhang B, Ji H, Yan D, Liu S, Shi B (2014) Lack of association of microvessel density with prognosis of renal cell carcinoma: evidence from meta-analysis. Tumor Biol 35(3):2769–2776CrossRef Zhang B, Ji H, Yan D, Liu S, Shi B (2014) Lack of association of microvessel density with prognosis of renal cell carcinoma: evidence from meta-analysis. Tumor Biol 35(3):2769–2776CrossRef
3.
go back to reference Srigley JR, Delahunt B (2009) Uncommon and recently described renal carcinomas. Mod Pathol 22(Suppl 2):S2–23CrossRefPubMed Srigley JR, Delahunt B (2009) Uncommon and recently described renal carcinomas. Mod Pathol 22(Suppl 2):S2–23CrossRefPubMed
4.
go back to reference Murphy WM, Grignon DG, Perlman EJ (2004) Tumors of the kidney, bladder, and related urinary structures. American Registry of Pathology, Washington Murphy WM, Grignon DG, Perlman EJ (2004) Tumors of the kidney, bladder, and related urinary structures. American Registry of Pathology, Washington
5.
go back to reference Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM (2001) Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32:590–595CrossRefPubMed Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM (2001) Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32:590–595CrossRefPubMed
6.
7.
go back to reference Thoenes W, Storkel S, Rompelt HJ, Moll R, Baum HP, Werner S (1988) Chromophobe cell renal carcinoma and its variants. A report in 32 cases. J. Pathol 155:277–287CrossRef Thoenes W, Storkel S, Rompelt HJ, Moll R, Baum HP, Werner S (1988) Chromophobe cell renal carcinoma and its variants. A report in 32 cases. J. Pathol 155:277–287CrossRef
8.
go back to reference Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Nat Cancer Inst 94:883–893CrossRefPubMed Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Nat Cancer Inst 94:883–893CrossRefPubMed
9.
go back to reference Grizzi F, Colombo P, Barbieri B et al (2001) Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 7:3305–3307PubMed Grizzi F, Colombo P, Barbieri B et al (2001) Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 7:3305–3307PubMed
10.
go back to reference Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324:1–8CrossRefPubMed Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324:1–8CrossRefPubMed
11.
go back to reference Grizzi F, Ceva-Grimaldi G, Dioguardi N (2001a) Fractal geometry: a useful tool for quantifying irregular lesions in human liver biopsy specimens. Ital J Anat Embryol 106:337–346PubMed Grizzi F, Ceva-Grimaldi G, Dioguardi N (2001a) Fractal geometry: a useful tool for quantifying irregular lesions in human liver biopsy specimens. Ital J Anat Embryol 106:337–346PubMed
12.
go back to reference Kovacs G, Akhtar M, Beckwith BJ et al (1997) The Heidelberg classification of renal cell tumours. J Pathol 80:992–993 Kovacs G, Akhtar M, Beckwith BJ et al (1997) The Heidelberg classification of renal cell tumours. J Pathol 80:992–993
13.
go back to reference Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al (20015). EAU Guidelines on Renal Cell Carcinoma 2014 Update. Eur Urol 67(5): 913–924 Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al (20015). EAU Guidelines on Renal Cell Carcinoma 2014 Update. Eur Urol 67(5): 913–924
14.
go back to reference Delahunt B, Srigley JR, Montironi R, Egevad L (2014) Advances in renal neoplasia: recommendations from the 2012 International Society of Urological Pathology Consensus Conference. Urology 83(5):969–974CrossRefPubMed Delahunt B, Srigley JR, Montironi R, Egevad L (2014) Advances in renal neoplasia: recommendations from the 2012 International Society of Urological Pathology Consensus Conference. Urology 83(5):969–974CrossRefPubMed
15.
go back to reference Poblet E, González-Palacios F, Jimenez FJ (1996) Different immunoreactivity of endotelial markers in well and poorly differentiated areas of angiosarcomas. Virchows Arch 428:217–221PubMed Poblet E, González-Palacios F, Jimenez FJ (1996) Different immunoreactivity of endotelial markers in well and poorly differentiated areas of angiosarcomas. Virchows Arch 428:217–221PubMed
16.
go back to reference Yilmazer D, Han U, Onal B (2007) A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma. Int Urol Nephrol 39:691–698CrossRefPubMed Yilmazer D, Han U, Onal B (2007) A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma. Int Urol Nephrol 39:691–698CrossRefPubMed
17.
go back to reference Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP (2002) The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 87:694–701CrossRefPubMedPubMedCentral Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP (2002) The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 87:694–701CrossRefPubMedPubMedCentral
18.
go back to reference Uzzan B, Nicolas P, Cucherat M, Perret GY (2004) Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64:2941–2955CrossRefPubMed Uzzan B, Nicolas P, Cucherat M, Perret GY (2004) Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64:2941–2955CrossRefPubMed
19.
go back to reference Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 94:1823–1832CrossRefPubMedPubMedCentral Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 94:1823–1832CrossRefPubMedPubMedCentral
20.
go back to reference Ruiz-Saurí A, Valencia-Villa G, Romanenko A, Pérez J, García R, García H, Benavent J, Sancho-Tello M, Carda C, Llombart-Bosch A (2016) Influence of exposure to chronic persistent low-dose ionizing radiation on the tumor biology of clear-cell renal-cell carcinoma. An Immunohistochemical and morphometric study of angiogenesis and vascular related factors. Pathol Oncol Res 22(4):807–815CrossRefPubMed Ruiz-Saurí A, Valencia-Villa G, Romanenko A, Pérez J, García R, García H, Benavent J, Sancho-Tello M, Carda C, Llombart-Bosch A (2016) Influence of exposure to chronic persistent low-dose ionizing radiation on the tumor biology of clear-cell renal-cell carcinoma. An Immunohistochemical and morphometric study of angiogenesis and vascular related factors. Pathol Oncol Res 22(4):807–815CrossRefPubMed
21.
go back to reference Joo HJ, Oh DK, Kim YS, Lee KB, Kim SJ (2004) Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int 93:291–296CrossRefPubMed Joo HJ, Oh DK, Kim YS, Lee KB, Kim SJ (2004) Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int 93:291–296CrossRefPubMed
22.
go back to reference Nativ O, Sabo E, Reiss A, Wald M, Madjar S, Moskovitz B (1998) Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma. Urology 51:693–696CrossRefPubMed Nativ O, Sabo E, Reiss A, Wald M, Madjar S, Moskovitz B (1998) Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma. Urology 51:693–696CrossRefPubMed
23.
go back to reference Yoshino S, Kato M, Okada K (1995) Prognostic significance of microvessel count in low stage renal cell carcinoma. Int J Urol 2:156–160CrossRefPubMed Yoshino S, Kato M, Okada K (1995) Prognostic significance of microvessel count in low stage renal cell carcinoma. Int J Urol 2:156–160CrossRefPubMed
24.
go back to reference MacLennan GT, Bostwick DG (1995) Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology 46:27–30CrossRefPubMed MacLennan GT, Bostwick DG (1995) Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology 46:27–30CrossRefPubMed
25.
go back to reference Minardi D, Lucarini G, Mazzucchelli R, Milanese G, Natali D, Galosi AB, Montironi R, Biagini G, Muzzonigro G (2005) Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens. J Urol 174:1208–1212CrossRefPubMed Minardi D, Lucarini G, Mazzucchelli R, Milanese G, Natali D, Galosi AB, Montironi R, Biagini G, Muzzonigro G (2005) Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens. J Urol 174:1208–1212CrossRefPubMed
26.
go back to reference Anastassiou G, Duensing S, Steinhoff G, Zorn U, Grosse J, Dallmann I, Kirchner H, Ganser A, Atzpodien J (1996) Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma. Oncology 53:127–132CrossRefPubMed Anastassiou G, Duensing S, Steinhoff G, Zorn U, Grosse J, Dallmann I, Kirchner H, Ganser A, Atzpodien J (1996) Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma. Oncology 53:127–132CrossRefPubMed
27.
go back to reference Imao T, Egawa M, Takashima H, Koshida K, Namiki M (2004) Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma. Int J Urol 11:948–953CrossRefPubMed Imao T, Egawa M, Takashima H, Koshida K, Namiki M (2004) Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma. Int J Urol 11:948–953CrossRefPubMed
28.
go back to reference Rioux-Leclercq N, Epstein JI, Bansard JY, Turlin B, Patard JJ, Manunta A, Chan T, Ramee MP, Lobel B, Moulinoux JP (2001) Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol 32:1209–1215CrossRefPubMed Rioux-Leclercq N, Epstein JI, Bansard JY, Turlin B, Patard JJ, Manunta A, Chan T, Ramee MP, Lobel B, Moulinoux JP (2001) Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol 32:1209–1215CrossRefPubMed
29.
go back to reference Sabo E, Boltenko A, Sova Y, Stein A, Kleinhaus S, Resnick MB (2001) Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 7:533–537PubMed Sabo E, Boltenko A, Sova Y, Stein A, Kleinhaus S, Resnick MB (2001) Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 7:533–537PubMed
30.
go back to reference Schraml P, Struckmann K, Hatz F, Sonnet S, Kully C, Gasser T, Sauter G, Mihatsch MJ, Moch H (2002) VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J Pathol 196:186–193CrossRefPubMed Schraml P, Struckmann K, Hatz F, Sonnet S, Kully C, Gasser T, Sauter G, Mihatsch MJ, Moch H (2002) VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J Pathol 196:186–193CrossRefPubMed
31.
go back to reference Cheng S-H, Liu J-M, Liu Q-Y, Luo D-Y, Liao B-.H, Li H, Wang K-J (2014). Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis. Int J Clin Exp Pathol 7(9): 5855–5863 Cheng S-H, Liu J-M, Liu Q-Y, Luo D-Y, Liao B-.H, Li H, Wang K-J (2014). Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis. Int J Clin Exp Pathol 7(9): 5855–5863
32.
go back to reference Ferician O, Cimpean AM, Ceasu AM, Dema A, Raica M, Cumpanas A (2016) Heterogeneous vascular patterns in renal cell carcinomas. Pol J Pathol 67(1):46–53CrossRefPubMed Ferician O, Cimpean AM, Ceasu AM, Dema A, Raica M, Cumpanas A (2016) Heterogeneous vascular patterns in renal cell carcinomas. Pol J Pathol 67(1):46–53CrossRefPubMed
33.
go back to reference Joshi S, Singh AR, Durden DL (2015) Pan-PI-3 kinase inhibitor SF 1126 shows antitumor and antiangiogenic activity in renal cell carcinoma. Cancer Chemother Pharmacol 75:595–608CrossRefPubMed Joshi S, Singh AR, Durden DL (2015) Pan-PI-3 kinase inhibitor SF 1126 shows antitumor and antiangiogenic activity in renal cell carcinoma. Cancer Chemother Pharmacol 75:595–608CrossRefPubMed
34.
go back to reference Schirner M, Hoffmann J, Menrad A, Schneider MR (1998) Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. Clin Cancer Res 4:1331–1336PubMed Schirner M, Hoffmann J, Menrad A, Schneider MR (1998) Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. Clin Cancer Res 4:1331–1336PubMed
35.
go back to reference Travnicek I, Branzovsky H, Kalusova K, Hess O, Holubec L, Pele KB, Ürge T, Hora M (2015) Tissue biomarkers in predicting response to sunitinib treatment of metastatic renal cell carcinoma. Anticancer Res 35:5661–5666PubMed Travnicek I, Branzovsky H, Kalusova K, Hess O, Holubec L, Pele KB, Ürge T, Hora M (2015) Tissue biomarkers in predicting response to sunitinib treatment of metastatic renal cell carcinoma. Anticancer Res 35:5661–5666PubMed
36.
go back to reference Porta C, Giglione P, Liguigli W, Paglino C (2015) Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity. Future Oncol 11:39–50CrossRefPubMed Porta C, Giglione P, Liguigli W, Paglino C (2015) Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity. Future Oncol 11:39–50CrossRefPubMed
37.
go back to reference Okoń K, Kawa R (2008) Microvascular network in renal carcinomas. Quantitative and tissue microarray immunohistochemical study. Pol J Pathol 59:107–115PubMed Okoń K, Kawa R (2008) Microvascular network in renal carcinomas. Quantitative and tissue microarray immunohistochemical study. Pol J Pathol 59:107–115PubMed
38.
go back to reference Tinini T, Rossi F, Claudio PP (2003) Molecular basis of angiogenesis and cancer. Oncogene 22:6549–6556CrossRef Tinini T, Rossi F, Claudio PP (2003) Molecular basis of angiogenesis and cancer. Oncogene 22:6549–6556CrossRef
39.
go back to reference Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60:1388–1393PubMed Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60:1388–1393PubMed
Metadata
Title
Distribution of Vascular Patterns in Different Subtypes of Renal Cell Carcinoma. A Morphometric Study in Two Distinct Types of Blood Vessels
Authors
Amparo Ruiz-Saurí
V. García-Bustos
E. Granero
S. Cuesta
M. A. Sales
V. Marcos
A. Llombart-Bosch
Publication date
01-07-2018
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2018
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-017-0262-y

Other articles of this Issue 3/2018

Pathology & Oncology Research 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine